The FDA cleared ION-L for skeletally mature patients with DDD from L3 to S1 who have failed conservative care.
Boca Raton, Florida-based SurGenTec designed ION-L to address the demands of posterior lumbar facet fixation while minimizing surgical footprint. Placed bilaterally through a posterior surgical approach, the system spans the facet joint interspace. The company engineered it for controlled, non-impact insertion to protect surrounding patient anatomy. Meanwhile, it reduces the need for extensive posterior exposure.
Key features include a zero-profile implant design and fenestrations and open barrels to support bone graft integration and fusion. Neutral joint positioning capabilities reduce the risk of unintended joint expansion during insertion. Engagement features help resist implant expulsion as well.
SurGenTec also says the system features Nanotex surface technology with controlled pore sizes. This attracts and retains bone marrow aspirate and growth factors to support osseointegration.
The company said it is now making ION-L commercially available, expanding its spine portfolio.
“ION-L reflects our continued commitment to building a comprehensive facet fixation platform that provides surgeons with consistent, reliable, and less invasive solutions across the spine,” said Travis Greenhalgh, CEO and founder of SurGenTec. “For decades, spinal fixation has relied on bulky hardware and invasive techniques. With ION-L, we have demonstrated that surgeons can achieve the same clinical goals through a less invasive, facet-based approach.”
